ACCELERATE DIAGNOSTICS INC
COM · CUSIP 00430H102
0
institutional holders
-1 vs Q2 2025
—reported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $2.1k (-325.2k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 85 |
| Q4 2022 | 73 |
| Q1 2023 | 68 |
| Q2 2023 | 50 |
| Q3 2023 | 2 |
| Q4 2023 | 2 |
| Q1 2024 | 1 |
| Q2 2024 | 1 |
| Q3 2024 | 1 |
| Q4 2024 | 1 |
| Q1 2025 | 1 |
| Q2 2025 | 1 |
| Q3 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 1 | 0 |
| Q1 2024 | 1 | 1 |
| Q2 2024 | 0 | 0 |
| Q3 2024 | 0 | 0 |
| Q4 2024 | 0 | 0 |
| Q1 2025 | 0 | 1 |
| Q2 2025 | 0 | 0 |
| Q3 2025 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| Birchview Capital, LP | Sold out | -325.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Indaba Capital Management, L.P.
13D · may seek influence
filed 2025-02-06
Stated purposeItem 4 of the Schedule 13D is hereby supplemented as follows: On February 4, 2025, the Fund purchased approximately $12.4 million in aggregate principal amount of the Issuer's New Convertible Notes from the holder of such notes. As a result of the acquisition of additional principal amount of New Convertible Notes, the Fund now owns a majority of the outstanding New Convertible Notes. Because the Fund beneficially owns a majority of the outstanding principal amount of New Convertible Notes, the Fund will have the ability to control any decision under the Indenture or the Security Agreement with respect to the New Convertible Notes that requires approval of the holders of a majority of the outstanding principal amount of the New Convertible Notes. Decisions requiring approval of the hold… Full filing |
9.9% |
Holders, Q3 2025
| Manager | Shares | Change |
|---|